Please use this identifier to cite or link to this item:
- Understanding the Structure, Activity and Inhibition of Chorismate Synthase from Mycobacterium tuberculosis
- Universidade Estadual Paulista (UNESP)
- Universidade de São Paulo (USP)
- Natl Inst Sci & Technol Immunol INCT III
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Financiadora de Estudos e Projetos (FINEP)
- FAPESP: 06/57122-7
- Tuberculosis is considered a worldwide health problem mainly due to co-infection with HIV and proliferation of multi-drug-resistant strains. The enzymes of the shikimate pathway are potential targets for the development of new therapies because they are essential for bacteria, but absent from mammals. The last step in this pathway is performed by chorismate synthase (CS), which catalyzes the conversion of 5-enolpyruvylshikimate-3-phosphate (EPSP) to chorismate. The aim of this article is to review the available information on chorismate synthase from Mycobacterium tuberculosis.
- Current Medicinal Chemistry. Sharjah: Bentham Science Publ Ltd, v. 18, n. 9, p. 1311-1317, 2011.
- Bentham Science Publ Ltd
- Chorismate synthase
- Mycobacterium tuberculosis
- shikimate pathway
- Acesso restrito
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.